These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17678982)

  • 1. Evaluation of the recurrent stone former.
    Chandhoke PS
    Urol Clin North Am; 2007 Aug; 34(3):315-22. PubMed ID: 17678982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient metabolic evaluation of patients with recurrent kidney stones.
    Leslie SW
    Ohio Med; 1989 Apr; 85(4):292-4. PubMed ID: 2717121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic evaluation at the time of the first renal lithiasis episode].
    del Valle EE; Spivacow FR; Zanchetta JR
    Medicina (B Aires); 1995; 55(1):69-74. PubMed ID: 7565040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic evaluation of urinary stone-former patients. Role of the urologist].
    Traxer O; Lechevallier E; Saussine C
    Prog Urol; 2008 Dec; 18(12):849-56. PubMed ID: 19033042
    [No Abstract]   [Full Text] [Related]  

  • 5. [Randomized trials in the prevention of recurrent calcium oxalate stones].
    Presne C; Monge M; Bataille P; el Esper N; Choukroun G; Fournier A
    Nephrologie; 2003; 24(6):303-7. PubMed ID: 14584297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A nephrologist's tasks in nephrolithiasis].
    Marangella M
    G Ital Nefrol; 2005; 22(1):16-27. PubMed ID: 15786374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice.
    Mardis HK; Parks JH; Muller G; Ganzel K; Coe FL
    J Urol; 2004 Jan; 171(1):85-8. PubMed ID: 14665850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function in patients with nephrolithiasis.
    Worcester EM; Parks JH; Evan AP; Coe FL
    J Urol; 2006 Aug; 176(2):600-3; discussion 603. PubMed ID: 16813897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones.
    Castiglione V; Pottel H; Lieske JC; Lukas P; Cavalier E; Delanaye P; Rule AD
    J Nephrol; 2020 Feb; 33(1):101-107. PubMed ID: 31222647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the kidney stone patient.
    Asplin JR
    Semin Nephrol; 2008 Mar; 28(2):99-110. PubMed ID: 18359391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic evaluation and medical therapy for stone formation.
    Krautschick AW
    Curr Opin Urol; 1999 Jul; 9(4):335-8. PubMed ID: 10459471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Randall's plaques in the pathogenesis of calcium stones.
    Matlaga BR; Coe FL; Evan AP; Lingeman JE
    J Urol; 2007 Jan; 177(1):31-8. PubMed ID: 17161996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium kidney stones. Diagnostic and preventive prospects].
    Arcidiacono T; Terranegra A; Biasion R; Soldati L; Vezzoli G
    G Ital Nefrol; 2007; 24(6):535-46. PubMed ID: 18278757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric urinary stone disease--does age matter?
    Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
    J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent kidney calculi. Metabolic examination and medical prevention].
    Johannesen O; Aaseth J; Frey H
    Tidsskr Nor Laegeforen; 1988 Feb; 108(5):387-9. PubMed ID: 3353932
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiology and management of calcium stones.
    Park S; Pearle MS
    Urol Clin North Am; 2007 Aug; 34(3):323-34. PubMed ID: 17678983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaphylaxis of nephrolithiasis.
    Jacobellis U
    Urol Int; 2007; 79 Suppl 1():51-5. PubMed ID: 17726353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of recurrent stones in idiopathic hypercalciuria.
    Gavras I
    N Engl J Med; 2002 May; 346(21):1667-9. PubMed ID: 12030261
    [No Abstract]   [Full Text] [Related]  

  • 19. Kidney stone disease. Experiences from Uppsala, Sweden.
    Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():207-11. PubMed ID: 6937997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urolithiasis--medical therapies.
    Spernat D; Kourambas J
    BJU Int; 2011 Nov; 108 Suppl 2():9-13. PubMed ID: 22085119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.